Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.

Thirty two patients with beta thalassaemia and sickle cell disease who were having regular blood transfusions were selected to test the efficacy and immunogenicity of low dose (2 micrograms or 0.1 ml) intradermal hepatitis B vaccine compared with the standard (20 micrograms or 1 ml) intramuscular do...

Full description

Saved in:
Bibliographic Details
Main Authors: Mok, Q, Underhill, G, Wonke, B, Aldouri, M, Kelsey, M, Jefferies, D
Format: Artigo
Language:Inglês
Published: 1989
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1791989/
https://ncbi.nlm.nih.gov/pubmed/2526622
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items